Ronald Muhlenkamp
Muhlenkamp & Co
Muhlenkamp & Co 13F holdings
Ronald Muhlenkamp's Portfolio
- Portfolio value:
- $242.91M~
- # of securities:
- 53 (-6)
- Reported for:
- 31 Mar 2016 (Q1)
- Latest filing date:
- 12 May 2016
What stocks did Ronald Muhlenkamp own in 2016 Q1?
What was Ronald Muhlenkamp's 2016 Q1 portfolio?
Muhlenkamp & Co has disclosed a total of 53 security holdings in their (2016 Q1) SEC 13F filing(s) with portfolio value of $242,911,000.
Muhlenkamp & Co's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Ronald Muhlenkamp's original 13F reports (2016 Q1) are the official SEC institutional disclosure documents covering all reported equity positions.
48 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bread Financial Holdings, Inc
|
10.99%
|
$220.00
|
-51.92%($105.77)
|
2013 Q2*
|
> 3 years
|
+0.08% (+101)
|
||||
|
|
Gilead Sciences Inc
|
8.24%
|
$91.86
|
+59.65%($146.66)
|
2013 Q2*
|
> 3 years
|
+0.01% (+15)
|
||||
|
|
Apple Inc
|
6.78%
|
$27.25
|
+1,044.49%($311.85)
|
2013 Q2*
|
> 3 years
|
-0.08% (-476)
|
||||
|
|
Bristol-Myers Squibb Company
|
5.58%
|
$63.88
|
+5.03%($67.09)
|
2014 Q1
|
~2.25 years
|
+0.21% (+445)
|
||||
|
|
Microsoft Corp
|
5.38%
|
$55.23
|
+783.44%($487.93)
|
2013 Q2*
|
> 3 years
|
-18.00% (-51.95K)
|
||||
|
|
ON Semiconductor Corp
|
5.01%
|
$9.59
|
+644.24%($71.38)
|
2014 Q3
|
~1.75 years
|
+0.10% (+1.29K)
|
||||
|
|
Hanesbrands Inc
|
4.68%
|
$28.34
|
|
2013 Q2*
|
> 3 years
|
+0.05% (+220)
|
||||
|
|
Teva Pharma Industries Ltd ADR
|
3.90%
|
$53.51
|
-30.77%($37.04)
|
2013 Q2*
|
> 3 years
|
+0.12% (+205)
|
||||
|
|
Allegiant Travel Company
|
3.85%
|
$178.06
|
-53.24%($83.27)
|
2013 Q2*
|
> 3 years
|
+0.18% (+95)
|
||||
|
|
SPIRIT AIRLINES INC
|
3.82%
|
$47.98
|
|
2013 Q2*
|
> 3 years
|
+0.11% (+210)
|
||||
Completely sold out
11 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
JPMorgan Chase & Co
|
2013 Q2*
|
> 2 years
|
|||
|
|
ARRIS INTERNATIONAL LTD
|
2015 Q4
|
~0.25 years
|
|||
|
|
Morgan Stanley
|
2013 Q2*
|
> 2 years
|
|||
|
|
Alerian MLP ETF
|
2015 Q4
|
~0.25 years
|
|||
|
|
COINSTAR LLC
|
2015 Q2
|
~0.75 years
|
|||
|
|
Epizyme Inc
|
2015 Q1
|
~1.00 year
|
|||
|
|
Energy Transfer Partners L.P
|
2015 Q4
|
~0.25 years
|
|||
|
|
PulteGroup Inc
|
2013 Q2*
|
> 2 years
|
|||
|
|
Williams Companies Inc
|
2015 Q4
|
~0.25 years
|
|||
|
|
SYNERON MEDICAL LTD
|
2015 Q4
|
~0.25 years
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".
* % of portfolio: the total can exceed 100%, e.g. when there are also options positions, which can be short.